Globus Medical Announces Board of Director Addition and Departure
December 13 2019 - 4:15PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, today announced the appointment of Robert
Douglas to the Company’s Board of Directors, and the departure of
Board member Kurt Wheeler, effective December 11, 2019.
Mr. Wheeler has assumed a role that precludes him from
serving on public company Boards.
Mr. Douglas has nearly thirty years of
experience in medical device technology, with particular expertise
in digital health. Currently Mr. Douglas serves as the
President and Chief Operating Officer in the Office of the CEO for
ResMed, Inc. (NYSE:RMD, ASX:RMD), a medical device and software
applications company specializing in cloud-connected devices that
diagnose, treat and manage respiratory disorders and improve care
in out-of-hospital settings. Mr. Douglas has been a leader at
ResMed for over 18 years and has extensive experience managing
large international markets. “Rob’s knowledge of the digital
health industry and global markets is well suited to support
Globus’ mission and our continued expansion in medical device
technology,” said Dave Demski, CEO.
Mr. Douglas will replace Kurt Wheeler who
departed the Globus Board of Directors this week. Mr. Wheeler has
served on the Company’s Board since July 2007. “Kurt has been
our Lead Director and an invaluable member of our Board for over
twelve years. His leadership, industry knowledge and trusted
advice have contributed to the success of Globus for many years,
and we wish him well in his future endeavors,” said David Paul,
Executive Chairman.
About Globus Medical, Inc.
Based in Audubon, Pennsylvania, Globus Medical,
Inc. was founded in 2003 by an experienced team of professionals
with a shared vision to create products that enable surgeons to
promote healing in patients with musculoskeletal disorders.
Additional information can be accessed at
www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release
other than statements of historical fact are forward-looking
statements and may be identified by their use of words such as
“believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,”
“continue,” “anticipate,” “intend,” “expect,” “plan” and other
similar terms. These forward-looking statements are based on
our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only
predictions and are subject to many risks, uncertainties and other
factors that may affect our businesses and operations and could
cause actual results to differ materially from those
predicted. These risks and uncertainties include, but are not
limited to, factors affecting our quarterly results, our ability to
manage our growth, our ability to sustain our profitability, demand
for our products, our ability to compete successfully (including
without limitation our ability to convince surgeons to use our
products and our ability to attract and retain sales and other
personnel), our ability to rapidly develop and introduce new
products, our ability to develop and execute on successful business
strategies, our ability to successfully integrate the international
operations acquired from Alphatec, both in general and on our
anticipated timeline, our ability to transition Alphatec’s
international customers to Globus products, our ability to realize
the expected benefits to our results from the Alphatec acquisition,
our ability to comply with laws and regulations that are or may
become applicable to our businesses, our ability to safeguard our
intellectual property, our success in defending legal proceedings
brought against us, trends in the medical device industry, general
economic conditions, and other risks. For a discussion of
these and other risks, uncertainties and other factors that could
affect our results, you should refer to the disclosure contained in
our most recent annual report on Form 10-K filed with the
Securities and Exchange Commission, including the sections labeled
“Risk Factors” and “Cautionary Note Concerning Forward-Looking
Statements,” and in our Forms 10-Q, Forms 8-K and other filings
with the Securities and Exchange Commission. These documents
are available at www.sec.gov. Moreover, we operate in an evolving
environment. New risk factors and uncertainties emerge from
time to time and it is not possible for us to predict all risk
factors and uncertainties, nor can we assess the impact of all
factors on our business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking
statements. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on any forward-looking
statements. Forward-looking statements contained in this
press release speak only as of the date of this press
release. We undertake no obligation to update any
forward-looking statements as a result of new information, events
or circumstances or other factors arising or coming to our
attention after the date hereof.
Contact:Brian KearnsSenior Vice President,
Business Development and Investor RelationsPhone: (610)
930-1800Email: investors@globusmedical.com www.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024